CXCR5 and neoplasm: CD200 also expressed in T cells, and played a crucial role in immunotherapy by secreting effector molecules, which contribute to improved anti-tumor activity.27 Thus, CD200+ CXCR5+ T cells identified in our study may demonstrate enhanced immunity potentially contributed to the response to immunotherapy.